TREVENTIS is a biotechnology company focused on diseases associated with protein misfolding. Treventis was founded in 2008. Treventis' headquarters is located in Toronto, Ontario, CA 4KD 472.
Treventis' Founder & CEO, Christopher J. Barden, currently...
Treventis's Founder & CEO, Christopher J. Barden, currently has an approval
rating of 89%. Treventis's primary competitors are Unchained Labs, Biodesy & InFlectis BioScience.